Liquid chromatography/tandem mass spectrometric analysis of penicillamine for its pharmacokinetic evaluation in dogs. (21st November 2020)

• Record Type: Journal Article
• Authors: Lehner, Andreas F.; Dirikolu, Levent; Johnson, Margaret; Buchweitz, John P.; Langlois, Daniel K.
• Is Part Of: Toxicology mechanisms and methods. Volume 30:Number 9(2020)
• Page Start: 687
• Page End: 702
• Publication Date: 2020-11-21
• Subjects: Penicillamine -- canine copper storage disease -- chelation therapy -- LC/MS/MS -- pharmacokinetics; Analytical toxicology -- Periodicals; Toxicology -- Periodicals; Toxicology -- Methodology -- Periodicals; 615.907
• DOI: 10.1080/15376516.2020.1814467
• Languages: English
• ISSNs: 1537-6516

Abstract

Abstract: Copper storage disease occurs in multiple dog breeds and is one of the most common causes of chronic hepatitis in this species. The disease is caused by hereditary defects in copper metabolism in conjunction with high dietary copper levels. The progressive copper accumulation leads to hepatitis, cirrhosis, and eventually death if left untreated. Copper chelators are critical in modulating the effects of this disease. It is therefore of significant practicality to understand the pharmacokinetic (PK) parameters of chelating agents, particularly since they are oftentimes quite expensive. A liquid chromatography-tandem mass spectrometric (LC/MS/MS) method was developed to measure plasma levels of one of the most common chelators, d -penicillamine. The compound was discovered to exist in two forms, monomeric and dimeric, and various chemical derivatizations were tried to force the compound into one form or the other. Eventually, the simplest approach was individual determination of penicillamine and its dimer, with summation of the two quantities. This enabled determination of canine PK parameters for penicillamine based on comparison of oral and intravenous administration of the drug, including time to maximum drug level (Tmax), concentration at maximum (Cmax), clearance (Cls) and volume of distribution (Vdss). The drug was found to exist predominantly in the dimeric form in plasma, which is incapable of chelating copper owing to lack of free sulfhydryl groups and must therefore provide a storage form of the drug in equilibrium with its monomeric form in vivo . Mechanisms are discussed for the electrospray-induced fragmentation of penicillamine as well as of its dimer.